✦ LIBER ✦

Improved Therapeutic Index of Lower Dose Topotecan Chemotherapy in Recurrent Ovarian Cancer

✍ Scribed by Michael Rodriguez; Peter G. Rose

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of lower-dose

✍ S.K. MITCHELL; L.F. CARSON; P. JUDSON; L.S. DOWNS JR 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Phase I dose escalation study of vinorel

✍ Matthew A Beldner; Carol A Sherman; Mark R Green; Elizabeth Garrett-Mayer; Uzair 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 278 KB

Efficacy and Hematologic Toxicity of Sal

✍ Sarah Cook; Richard Penson; Linda Duska; Najmosama Nikrui; Annekathryn Goodman; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Improved tolerance of primary chemothera

✍ Amanda Nickles Fader; Vivian von Gruenigen; Heidi Gibbons; Fadi Abushahin; David 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 344 KB

39 Topotecan versus treosulfan in recurr

✍ S. Loibl; W. Meier; A. du Bois; W. Kuhn; J. Pfisterer; R. Kimmig; S. Olbricht; B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Cycles of Dose-Intensive Chemotherapy wi

✍ Mark A. Morgan; Edward A. Stadtmauer; Selina M. Luger; David L. Porter; Patricia 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 74 KB